65 results
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
25 Mar 24
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
4:05pm
to fund our planned operations for at least the next twelve months.
Research and Development Expenses (R&D) Expenses – R&D expenses decreased by $3.5
8-K
EX-99.1
970e 5g0ndncr50
6 Nov 23
Fennec Pharmaceuticals Announces Third Quarter 2023
7:38pm
8-K/A
EX-99.1
njzvfgr
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-99.1
aqy8 7wgwudbx3b
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
arftcmvvblqxa q8yjfh
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am